The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Designing Anticancer Peptides by Constructive Machine Learning
Abstract
Constructive (generative) machine learning enables the automated generation of novel chemical structures without the need for explicit molecular design rules. This study presents the experimental application of such a deep machine learning model to design membranolytic anticancer peptides (ACPs) de novo. A recurrent neural network with long short‐term memory cells was trained on α‐helical cationic amphipathic peptide sequences and then fine‐tuned with 26 known ACPs by transfer learning. This optimized model was used to generate unique and novel amino acid sequences. Twelve of the peptides were synthesized and tested for their activity on MCF7 human breast adenocarcinoma cells and selectivity against human erythrocytes. Ten of these peptides were active against cancer cells. Six of the active peptides killed MCF7 cancer cells without affecting human erythrocytes with at least threefold selectivity. These results advocate constructive machine learning for the automated design of peptides with desired biological activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Speech recognition with deep recurrent neural networks
Graves, A., Mohamed, A.-R., & Hinton, G. (2013) · 2013 IEEE International Conference on Acoustics, Speech and Signal Processing · doi:10.1109/icassp.2013.6638947 · Cited by 8,893
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Deep Learning in Drug Discovery
Gawehn, E., Hiss, J. A., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201501008 · Cited by 723
Self-citationDe Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
Self-citationRecurrent Neural Network Model for Constructive Peptide Design
Müller, A. T., Hiss, J. A., & Schneider, G. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00414 · Cited by 270
Self-citation
Research works printed but not linked: 14
- Segler M. H. S., 2018, ACS Cent. Sci., 4, 120, 10.1021/acscentsci.7b00512 · DOI · Paper page
- White D., 2010, J. Chem. Inf. Model., 50, 1257, 10.1021/ci9004089 · DOI
- Gupta A., 2018, Mol. Inf., 37, 1700111, 10.1002/minf.201700111 · DOI · Paper page
- T. Mikolov G. Zweig inIEEE Spoken Language Technology Workshop (SLT) 2012 234–239. · DOI · Paper page
- Gabernet G., 2016, MedChemComm, 7, 2232, 10.1039/C6MD00376A · DOI
- Tyagi A., 2015, Nucleic Acids Res., 43, 837, 10.1093/nar/gku892 · DOI · Paper page
- Usmani S. S., 2017, PLoS One, 12, 0181748, 10.1371/journal.pone.0181748 · DOI · Paper page
- Riedl S., 2011, Chem. Phys. Lipids, 164, 766, 10.1016/j.chemphyslip.2011.09.004 · DOI · Paper page
- Sammon J. W., 1969, IEEE Trans. Comput., 18, 401, 10.1109/T-C.1969.222678 · DOI · Paper page
- Andrä J., 1999, Med. Microbiol. Immunol., 188, 117, 10.1007/s004300050113 · DOI
- Schröder-Borm H., 2005, FEBS Lett., 579, 6128, 10.1016/j.febslet.2005.09.084 · DOI
- Nagarajan D., 2018, J. Biol. Chem., 293, 3492, 10.1074/jbc.M117.805499 · DOI
- Simões R. S., 2018, Front. Pharmacol., 9, 74, 10.3389/fphar.2018.00074 · DOI
- Huang X., 1991, Adv. Appl. Math., 12, 337, 10.1016/0196-8858(91)90017-D · DOI · Paper page
Cited by
Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., Veselov, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565644 · Cited by 849
Deep learning for molecular design—a review of the state of the art
Elton, D. C., Boukouvalas, Z., Fuge, M. D., & Chung, P. W. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00039a · Cited by 683
Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations
Das, P., Sercu, T., Wadhawan, K., Padhi, I., Gehrmann, S., Cipcigan, F., Chenthamarakshan, V., Strobelt, H., dos Santos, C., Chen, P.-Y., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00689-x · Cited by 414
Chiangjong, W., Chutipongtanate, S., & Hongeng, S. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5099 · Cited by 388
Geometric deep learning on molecular representations
Atz, K., Grisoni, F., & Schneider, G. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00418-8 · Cited by 373
Self-citationAutonomous Discovery in the Chemical Sciences Part I: Progress
Coley, C. W., Eyke, N. S., & Jensen, K. F. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201909987 · Cited by 317
Accelerating antibiotic discovery through artificial intelligence
Melo, M. C. R., Maasch, J. R. M. A., & de la Fuente-Nunez, C. (2021) · Communications Biology · doi:10.1038/s42003-021-02586-0 · Cited by 234
Deep Learning in Protein Structural Modeling and Design
Gao, W., Mahajan, S. P., Sulam, J., & Gray, J. J. (2020) · Patterns · doi:10.1016/j.patter.2020.100142 · Cited by 227
Artificial intelligence in medicine: what is it doing for us today?
Becker, A. (2019) · Health Policy and Technology · doi:10.1016/j.hlpt.2019.03.004 · Cited by 137
Bridging machine learning and peptide design for cancer treatment: a comprehensive review
Rezaee, K., & Eslami, H. (2025) · Artificial Intelligence Review · doi:10.1007/s10462-025-11148-3 · Cited by 34
(2022) · doi:10.1038/s41598-022-13227-9 · Cited by 12
Metadata
- Authors
- Grisoni, F., Neuhaus, C. S., Gabernet, G., Müller, A. T., Hiss, J. A., & Schneider, G.
- Venue
- ChemMedChem
- Publisher
- Wiley
- Published
- 2018-05-29
- Volume
- 13
- Issue
- 13
- Pages
- 1300-1302
- ISSN
- 1860-7179
- 1860-7187
- Cited by
- 107
- References
- 5
- Language
- en
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII2_160699, 200021_157190, IZSEZ0_177477)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.